Arcutis Biotherapeutics (ARQT) Non Operating Income (2019 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Non Operating Income of -$4.2 million for Q2 2023, down 167.76% year-over-year from $6.2 million in Q2 2022, and down 10.25% quarter-over-quarter from -$3.8 million in Q1 2023.
Arcutis Biotherapeutics (ARQT) Non Operating Income (2019 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Non Operating Income history runs 5 years deep, the most recent figure standing at -$4.2 million for Q2 2023.
- In Q2 2023, Non Operating Income fell 167.76% year-over-year to -$4.2 million; the TTM figure through Jun 2023 stood at -$14.6 million (down 354.43% YoY), while the FY2022 annual figure was -$9.8 million, down 5782.66% from the prior year.
- Non Operating Income for Q2 2023 stood at -$4.2 million, down from -$3.8 million in the prior quarter.
- The five-year high for Non Operating Income was $638000.0 in Q1 2020, with the low at -$4.2 million in Q2 2023.
- The 5-year median for Non Operating Income is $57500.0 (2021), against an average of -$867666.7.
- The sharpest annual moves came in 2020 and 2022: Non Operating Income soared 117.01% in 2020, then slumped 8887.5% in 2022.
- Arcutis Biotherapeutics' Non Operating Income stood at $426000.0 in 2019, then tumbled by 96.48% to $15000.0 in 2020, then plunged by 366.67% to -$40000.0 in 2021, then plunged by 8887.5% to -$3.6 million in 2022, then slipped by 17.61% to -$4.2 million in 2023.
- Business Quant data shows ARQT's Non Operating Income at -$4.2 million in Q2 2023, -$3.8 million in Q1 2023, and -$3.6 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -139.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 12.40 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -51.63 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -53.64 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn | -1.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.28 Mn |
| Jun 30, 2025 | -933,000.00 |
| Jun 30, 2023 | -4.23 Mn |
| Mar 31, 2023 | -3.84 Mn |
| Dec 31, 2022 | -3.60 Mn |
| Sep 30, 2022 | -2.96 Mn |
| Jun 30, 2022 | -1.58 Mn |
| Mar 31, 2022 | -1.70 Mn |
| Dec 31, 2021 | -40,000.00 |
| Sep 30, 2021 | 98,000.00 |
| Jun 30, 2021 | 72,000.00 |
| Mar 31, 2021 | 43,000.00 |
| Dec 31, 2020 | 15,000.00 |
| Sep 30, 2020 | 99,000.00 |
| Jun 30, 2020 | 215,000.00 |
| Mar 31, 2020 | 638,000.00 |
| Dec 31, 2019 | 426,000.00 |
| Sep 30, 2019 | 168,000.00 |
| Jun 30, 2019 | 248,000.00 |
| Mar 31, 2019 | 294,000.00 |